When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 19 Hits
  • Search Condition : Filter (MeSH = Antibodies, Monoclonal / therapeutic use*)
Species Resource Title
Human and Animal Cells HuH-6(RCB1367) Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
Human and Animal Cells J774.1(RCB0434) Anti-protein-bound polysaccharide-K monoclonal antibody binds the active structure and neutralizes direct antitumor action of the compound.
Human and Animal Cells J#176-3.2(RCB1918) Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agents.
Human and Animal Cells KP4(RCB1005) Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.
Human and Animal Cells LM8(RCB1450) Radiation Enhances the Efficacy of Antitumor Immunotherapy with an Immunocomplex of Interleukin-2 and Its Monoclonal Antibody.
Human and Animal Cells CW-2(RCB0778) , MKN-7(RCB3687) Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action.
Human and Animal Cells Colon-26(RCB2657) , B16/BL6(RCB2638) Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.
Human and Animal Cells MKN1(RCB1003) Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.
Human and Animal Cells Ba/F3(RCB0805) , A431 Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma.
Human and Animal Cells LM8(RCB1450) The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma.
Human and Animal Cells Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Human and Animal Cells Jurkat(RCB0806) Development of a cell-based assay measuring the activation of FcγRIIa for the characterization of therapeutic monoclonal antibodies.
Human and Animal Cells KLM-1(RCB2138) Combination treatments with the PKC inhibitor, enzastaurin, enhance the cytotoxicity of the anti-mesothelin immunotoxin, SS1P.
Human and Animal Cells A549(RCB0098) , PC-14(RCB0446) Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor.
Human and Animal Cells Lu-135(RCB0468) , HMV-I(RCB0004) Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.
Human and Animal Cells ACC-MESO-4(RCB2293) Antitumor activity of anti-C-ERC/mesothelin monoclonal antibody in vivo.
Human and Animal Cells K562 , Jurkat(RCB0806) CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma.
Human and Animal Cells MC3T3-E1(RCB1126) Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
DNA material pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) , CS-CDF-CG-PRE (RDB04379). Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.